Intellia Therapeutics, Inc.
Developing gene editing treatments
- B2B
About Intellia Therapeutics, Inc.
Leading genome editing company focusing on developing curative gene editing treatments using CRISPR/Cas9 technology to transform the lives of patients with severe diseases
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2014
- Revenue
- $67.7MFY2025, publicly reported
- Website
- intelliatx.com
- linkedin.com/company/intelliatx
Intellia Therapeutics, Inc. at a glance
Intellia Therapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in cambridge, massachusetts, United States.
Intellia Therapeutics, Inc. was founded in 2014.
Intellia Therapeutics, Inc. has 251–1,000 employees.
Intellia Therapeutics, Inc.'s revenue is $67.7M (FY2025, publicly reported).
Selling to companies like Intellia Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies